Home
Conditions
Lymphoma, B-Cell

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

1,618 public trials 340 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Not Yet Recruiting

Lymphodepletion With Low Dose Total Body Irradiation Before Standard of Care Tisagenlecleucel for the Treatment of Relapsed and Recurrent Large B-cell Lymphoma

NCT07676877

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Not Yet Recruiting

Glofitamab Combined With Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

NCT07669194

Conditions: Diffuse Large B-Cell Lymphoma (DLBCL), Disease Attributes, Hemic and Lymphatic Diseases, +13 more
Locations: Second Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Not Yet Recruiting

Epcoritamab in Combination With Dose Adjusted EPOCH-R for High-risk Burkitt Lymphoma (BL), The BEDROCK Study

NCT07662928

Conditions: Adult Burkitt Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Not Yet Recruiting

Neurocognitive Assessment in Long-Term Survivors of Lymphoma

NCT07652476

Conditions: Classic Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, +11 more
Locations: Clinica di Ematologia, AOU Ospedali Riuniti Ancona, Italy

Divisione di Oncologia e dei Tumori immuno-correlati - IRCCS Centro di Riferimento Oncologico di Aviano Aviano, Italy

U.O.C Ematologia - IRCCS Istituto Tumori Giovanni Paolo II Bari, Italy

U.O.C. Ematologia Ospedale Civile di Legnano - ASST Ovest Milanese Legnano, Italy

View Trial Details

Not Yet Recruiting

Molecular and Cellular Characterization of MALT Lymphoma

NCT07376330

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: IRCCS Ospedale San Raffaele Milan, Italy

View Trial Details

Not Yet Recruiting

Connected Blood Pressure Monitoring in Patients With Hematologic Malignancies Initiating Covalent BTK Inhibitors

NCT07592481

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +34 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Rituximab Maintenance Versus Observation After R2 Induction in Previously Untreated Marginal Zone Lymphoma

NCT07654465

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Sun yat-sen university cancer center Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia

NCT07313852

Conditions: B-ALL, B-Cell Acute Lymphoblastic Leukemia, Adult, B-cell Acute Lymphoblastic Leukemia, +17 more
Locations: Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York, United States

View Trial Details

Not Yet Recruiting

HEME-25: Open-Label Feasibility Study of Elranatamab Utilized in Newly Diagnosed Plasmablastic Lymphoma With or Without HIV

NCT07647432

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +26 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Axatilimab + CAR-T for High-Risk Lymphoma

NCT07638982

Conditions: Diffuse Large B Cell Lymphoma (DLBCL), Digestive System Diseases, Follicular Grade 3 Lymphoma, +21 more
Locations: Northside Hospital Atlanta, Georgia, United States

View Trial Details

Lymphoma, B-Cell

Lymphoma, B-Cell trial results

Related conditions